商品名：Cipro and generic brands
Fluoroquinolone antibacterial. Acts to inhibit DNA gyrase and cell DNA and RNA synthesis. Bactericidal. Broad antimicrobial activity. Ciprofloxacin is active against gram-negative bacilli, including Enterobacteriaceae, and some gram-positive cocci, including Staphylococcus. Ciprofloxacin is more active against Pseudomonas aeruginosa than other fluoroquinolones, but resistance is possible. Multi-resistant bacteria, including gram-negative bacilli of the Enterobacteriaceae, and methicillin- resistant strains of Staphylococcus, are likely to be resistant to ciprofloxacin and other fluoroquinolone
Ciprofloxacin, although a human drug, has been used in small animals for treatment of a wide variety of infections, including skin infections, pneumonia, and soft tissue infections. Ciprofloxacin is not registered for animals. However, it can be prescribed by veterinarians, as long as it is not administered to animals that produce food or are intended for food. The administration of ciprofloxacin to animals is considered extralabel and subject to other extralabel restrictions. The variable and potentially low ciprofloxacin oral availability for dogs and cats suggests that doses should be highe
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
腎功能調整：Reduce dose in renal impairment
腎功能調整：Reduce dose in renal impairment
核對環丙沙星活性部分、鹽型、水合物、強度基準與精確成品 確認物種、成熟度、感染部位與是否確為細菌感染 依疾病情境取得並正確解讀培養與獸醫藥敏資料 評估腎肝功能、神經與關節病史、生殖狀態及全部共用藥物 核對所在地法規、食品鏈身分與抗菌藥治理要求 設定療效、失敗、不耐受、停止與救援計畫
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。